Sign Up to like & get
recommendations!
0
Published in 2017 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2017.08.435
Abstract: Patients with Attention Deficit/Hyperactivity Disorder (ADHD) and comorbid Substance Use Disorders (SUD) are increasingly being treated with central stimulant medication despite limited evidence for its effectiveness. Lack of longitudinal follow-up studies of dosing and adverse…
read more here.
Keywords:
comorbid substance;
deficit hyperactivity;
hyperactivity disorder;
methylphenidate doses ... See more keywords